These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17094491)

  • 1. Effects of serum on (-)-gossypol-suppressed growth in human prostate cancer cells.
    Huang YW; Wang LS; Chang HL; Ye W; Sugimoto Y; Dowd MK; Wan PJ; Lin YC
    Anticancer Res; 2006; 26(5A):3613-20. PubMed ID: 17094491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
    Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
    Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
    Huang YW; Wang LS; Chang HL; Ye W; Dowd MK; Wan PJ; Lin YC
    Anticancer Res; 2006; 26(3A):1925-33. PubMed ID: 16827126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6.
    Nonomura Y; Nagasaka K; Hagiyama H; Sekine C; Nanki T; Tamamori-Adachi M; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2006 Jul; 54(7):2074-83. PubMed ID: 16802342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGFbeta/Akt signaling.
    Jiang J; Ye W; Lin YC
    Int J Mol Med; 2009 Jul; 24(1):69-75. PubMed ID: 19513537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
    Kim YC; Chen C; Bolton EC
    PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
    Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K; Kumagai T; Shimizu T; Takeda K
    Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of a novel erythrocyte-derived depressing factor on blood vessels of renovascular hypertensive rats.
    Pang H; Wen YY; Ma N; Wang YT; Shi L
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):393-8. PubMed ID: 17439406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
    Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression.
    Chung KS; Cho SH; Shin JS; Kim DH; Choi JH; Choi SY; Rhee YK; Hong HD; Lee KT
    Carcinogenesis; 2013 Feb; 34(2):331-40. PubMed ID: 23125221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells.
    Ligueros M; Jeoung D; Tang B; Hochhauser D; Reidenberg MM; Sonenberg M
    Br J Cancer; 1997; 76(1):21-8. PubMed ID: 9218727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
    Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.
    Liu S; Kulp SK; Sugimoto Y; Jiang J; Chang HL; Dowd MK; Wan P; Lin YC
    Anticancer Res; 2002; 22(1A):33-8. PubMed ID: 12017312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
    Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
    Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
    Zhuang SH; Burnstein KL
    Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.